EMIF: E-managing the Future of Health Data

16th-17th March 2015, Budapest

Presentations

Click on the names to download specific presentations or scroll to the bottom to get the whole pack.

Introduction

  • Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceutica; Coordinator EMIF

Discovery: Real World Evidence as a Tool for Translation

  • Johan Liwing, Director Market Access RWE Partnerships, Global Commercial Strategy Organization, Janssen-Cilag AG
  • John Gallacher, Professor, University of Oxford, Medical Sciences Division, Director, MRC Dementias Platform UK
  • Ferran Sanz, Director, GRIB
  • Tõnu Esko, Deputy Director of Research at Estonian Genome Center, University of Tartu

Development: Optimising Execution, Feasibility and Efficacy

  • Dipak Kalra, President, EuroRec; EHR4CR
  • Iain Buchan, Clinical Professor in Public Health Informatics, Centre for Health Informatics, University of Manchester
  • Alison Bourke, Scientific Director, Real World Evidence, IMS Health

Deployment: Market Access, Pharmacovigilance, and Effectiveness

  • Rients van Wijngaarden, Senior Data Scientist, PHARMO Institute
  • Johan Van Bussel, Head of the department healthdata.be, Belgian Scientific Institute Public Health
  • Sarah Garner, Associate Director Science Policy and Research, National Institute for Health and Clinical Excellence (NICE)
  • Andrew Roddam, Vice President & Global Head Epidemiology at GSK

The Opportunities for Real World Data for research

  • Richard Bergstrom, Director General, EFPIA
  • Ann Martin, Principal Scientific Manager, IMI – replaced by Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceutica; Coordinator EMIF
  • Balázs Fürjes, Director, EIT Health InnoStars
  • Miklós Bacskai, Chief Strategy & Business Development Officer, Healthware

DOWNLOAD ALL PRESENTATIONS HERE

Supported by

2018-03-06T11:54:22+00:00